burst! The high-end vaccine company that has been "protected" by Tsai Ing-wen, Chen Shizhong and others may be in trouble.
High-end vaccine stock listed company and its parent company broke out in insider trading and were raided in 16 places by the inspection team. Affected by this bad news, on the last trading day of December 30, 2022, the stocks of the two companies fell sharply after opening .
The soldiers searched 16 places overnight, and high-end stocks were exposed to insider trading
High-end vaccines Parent company Kiya Chairman Zhang Shizhong
December 30, the last trading day of 2022, was hit by negative insider trading. After the high-end company and parent company Kiya opened the Taiwan stock market , 's stock price plummeted.
The high-end company whose stocks are listed on the OTC is a company that manufactures high-end vaccines. Because of the outbreak of insider trading, irregular transactions and other cases with its parent company Kiya Corporation, on the 29th, the Taipei Shilin District Prosecutor’s Office directed the Taipei City Investigation Division of the Investigation Bureau to conduct 16 units to search the residences of Kiya Company and related criminal suspects, and interviewed 18 people including Zhang Shizhong, chairman of Kiya Company. After a group of people were transferred to the Shilin District Prosecutor’s Office, the prosecutor stayed overnight for investigation.
As early as June 2021, the Shilin District Procuratorate established a task force and the Major Economic Group was responsible for the investigation. During this period, it was reported that the so-called high-end vaccine had successfully "unblocked the blindness". Health units such as the Philippines, Malaysia, and Indonesia contacted high-end companies for clinical trials of vaccines. Since then, the stock prices of high-end stocks have been like "turbulence". After ups and downs, the market value once increased several times.
During the filing of the case, the " High Procuratorate " sent a letter to investigate, and the chief prosecutor led two prosecutors to conduct an in-depth investigation. At the same time, they also requested relevant information from the "Financial Supervisory Commission" and the Securities Cabinet Trading Center.
According to reports such as the Taiwanese media "Business Times", after investigation, it was found that high-end companies were suspected of insider trading before announcing major bullish and bad news from February 2020 to July 2021. After a long-term task force sorted out investor transaction data, and through fund inspection and other methods, it was found that insiders were suspected of leaking information to their relatives and friends to buy high-end company stocks. Now, prosecutors believe that the time is ripe, so they are investigating the case together with its parent company, Gya.
Shilin District Prosecutor’s Office
Late at night on December 29, Kiya Company issued a temporary announcement, stating that it would cooperate with the Bureau of Investigation in relevant investigations, and emphasized that the company’s operations were normal and its finances would not be affected. Its over-the-counter subsidiary High-End Company also made a statement overnight, admitting that two non-supervisory junior employees at the Zhubei factory were investigated and interviewed due to their personal stock status, and the location where they were searched was the employee's residence. By around 10 p.m., the two employees were asked to return without posting bail.
The Shilin District Prosecutor’s Office stated that it will actively analyze and compare the criminal evidence seized on the 29th based on the attitude of not being in vain and not being indulged in, to maintain the fairness and justice of market transactions, protect the rights and interests of investors, and improve market development.
For a long time, Taiwan’s high-end vaccines have high risks and unknown efficacy, and ordinary people have continued to question them. This investigation started with suspected insider trading and launched an investigation into the high-end company and its parent company Kya. It is not yet known what the results will be. If inspections are not "raised high and dropped gently", if we can follow the clues, we may be able to uncover the chain of interests behind high-end vaccines during the investigation and give everyone the truth.
The investigation launched this time to track down the high-end vaccine company and its parent company Kiya Company for suspected insider trading stock trading . Lanying public opinion representative Zeng Mingzong disputed the timing of the investigation. He said that high-end vaccines are fully cultivated by the government, the hospital, and the "Ministry of Health and Welfare". The company's governance is so poor that it requires the head of the "Ministry of Health and Welfare" Xue Ruiyuan to step down, otherwise the Kuomintang group will not give up.
Blue Member Lai Shibao even pointed out that the stock prices of high-end companies have soared to NT$400. The middle price difference is so high that someone has calculated it. If you sell it at a high point, you can earn NT$100. 60 billion to 70 billion yuan. With such a large number, the "Financial Supervisory Commission" resident prosecutor once transferred high-end cases. If the "Financial Supervisory Commission" resident prosecutor did not have conclusive evidence, he would not take action. As a result, such an obvious matter was not moved before the election. After all, it was political considerations!
Will the high-end insider trading case be the straw that breaks the DPP’s back?
Questioned the prosecutor’s timing in handling the case
An insider trading case broke out between
High-end Company and its parent company Kiya Company. On December 29, the Shilin District Prosecutor’s Office directed the Taipei City Investigation Division to search 16 places including the residences of Kiya Company and criminal suspects. After an overnight interrogation, Kiya Company Chairman Zhang Shizhong posted a bail of 300,000 yuan, which aroused great attention from the island society.
Representatives of the Blue Camp held a press conference and questioned the timing of handling the case. "It was transferred nine times and only moved after the election. The inspection and adjustment are really 'high-end'." Zeng Mingzong, the general manager, pointed out at the press conference that Giya is a major shareholder of high-end companies and has a strong background. In the past, there were continuous and 20 price limits. Because the drug solution was not as good as expected, Giya's stock had a major stock speculation incident and its image was very bad.
A high-end company, a company that the Tsai Ing-wen administration has devoted all its efforts to protect and cultivate, actually has insider trading. If a company has poor governance, will the public trust its products?
In fact, over the past two years, many people on the island have pointed out that high-end vaccines have been a scam from the beginning. From the beginning of vaccine design, to the use of the so-called world's only immune bridging method, and then to not following the right path and being authorized for emergency use, the Taiwan government purchased 500 doses of high-end vaccines that are not recognized internationally at a high price. They are high-risk and have no known efficacy. Isn't it a scam?
High-end vaccine companies had no experience in producing sub-protein vaccines in the past, and relied on clinging to powerful people, the Food and Drug Administration, Chen Shizhong's "Ministry of Health and Welfare" and others to protect it. Previously, Taipei City, which is dominated by Ko Wenzhe, internally blocked the purchase of vaccines on its own, and externally blocked donations from Terry Gou, Tzu Chi, and Fo Guang Shan to create a vaccine "gap period" for the injection of high-end vaccines. Can you say there are no problems behind this?
High-end company
According to reports, the Taipei City Investigation Department divided 16 troops to search Gia Corporation and other places, and summoned a total of 18 people, including Gia Biotechnology Chairman Zhang Shizhong, to report to the case, and 13 of them were returned without bail.
Beginning at around 12 a.m. on December 20, Gia chairman Zhang Shizhong’s sister, Yunchen Electronics founder Zhang Ziling, Gia director Huang Ziliang and his wife, and Gia’s former chief financial officer Ou Chaoquan were also transferred to the Shilin District Prosecutor’s Office for review. At 4 a.m. on the 30th, Zhang Shizhong was transferred to the Shilin District Prosecutor's Office for reinterrogation. After the interrogation, the prosecutor ordered him to be released on bail in NT$300,000 pending trial.
Later, Zhang Ziling and her husband, Huang Ziliang, a director of Gia, were released on bail pending questioning at NT$500,000. In addition, Ou Chaoquan was released on bail of NT$100,000. Another woman surnamed Shi was released on NT$100,000 bail, and a man surnamed Wang was released on NT$50,000 bail pending trial.
On July 19, 2021, Taiwan's self-produced high-end vaccine quickly passed the emergency use authorization (EUA) under the "escort" of Tsai Ing-wen's administration. The "CDC" did not provide relevant information on the protective power of the vaccine, which triggered social controversy on the island at that time. When faced with doubts, Chen Shizhong, then the head of the health and welfare department, only responded rashly, "It is better to have immunization than not." At that time, many people said, had the IQ of Taiwanese people been weakened? !
html On the 329th, when media person Huang Yangming wrote an article, he couldn't help but lamented, "Sure enough, the defeat of the ruling party will change many things..." He even pointed out: In October 2021, Chen Yongcheng, chairman of the OTC Buying Center, confirmed that since November 2020, there have been "abnormal" transactions in high-end stocks, and they have been transferred for inspection five times.By October this year, it had been transferred nine times. He lamented: "Sure enough, the defeat of the ruling party will change many things..."
Taiwanese netizens said, "Get the cakes and black tea ready," and "Just buy the drinks and biscuits, and get ready to watch the show." Some netizens pointed out: "Inspection is really the biggest trend, and the judiciary is a joke. Seeing that the DPP is about to fall, now hurry up and grab the victory. A three-year-old child can see that there are big problems in the high-end, but they have to wait for this opportunity to act." Some said: "The Ministry of Health and Welfare" and Chen Shizhong are not suspected of being involved in the case? "
Tsai Ing-wen claims to be injected with high-end vaccines
Three years since the outbreak, there are two new crown vaccines in development on Taiwan's main island, one of which is suspected of insider trading. The other high-end vaccine is the Lianya vaccine. Although the two vaccines appeared at the same time, their fates were very different. Even though the public doubts continued, the high-end vaccine was given the green light. In contrast, the Lianya vaccine was like a "stepmother" and had a bad fate, and even fell into a dispute over management rights.
Lianya vaccine. After Yayao was listed on the IPO last year, its stock price soared, once exceeding that of high-end vaccines. After the application for emergency authorization was blocked, misfortunes never come singly. In January this year, Lianya Biotech was accused of insider trading. 17 people, including the executive deputy general manager of Lianya Biotech and an executive named Fu, were summoned. Later, these two people were required to post bail of NT$3 million and NT$6 million respectively. This matter aroused great concern on the island.
Guo Zhengliang, a professor at the Chinese Culture University and a well-known mouthpiece on the island, pointedly pointed out at the time that Lianya's stock price increased six times, and the prosecutor launched a large-scale search with 22 teams. 17 people were summoned to the case. Why is it okay that the high-end vaccine stock price increased 13 times? Guo Zhengliang questioned: "(Note: Refers to insider trading) Are there really no high-end ones? That's because you didn't check it at all! "
Lianya was investigated at the beginning of this year, while the high-end company and its parent company Gya were not investigated until the last few days of the year. The same vaccine company, the same direction of handling the case, but the timing is different. Don't you think there is a problem? In fact, there has been constant controversy all along the way because high-end vaccines are not "high-end". However, because Tsai Ing-wen, Chen Shizhong and their group are protecting them in every possible way, and often cover up their accusations for their own interests, even Chen Shui-bian has Unable to stand it, criticisms came one after another.
High-end was suspected of insider trading. Many people called for not only the stock transactions to be investigated, but also the chain of interests behind it. Even officials to the public should be investigated to give the public an explanation.
Will the high-end vaccine insider trading case be the straw that breaks the DPP’s back? Take a look and then talk.
